$AAPL, $FB, $INTC, $PCRX, $WPX
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is the list for Monday, 27 January, as follows:
Apple Inc. (NASDAQ:AAPL) was reiterated as Outperform and the formal price target was lifted to 400 from 350 at Wedbush Securities, with the services and a 5G iPhone supercycle coming.
Facebook Inc. (NASDAQ:FB) was reiterated as Outperform with a 250 target price at Wedbush, with the firm calling for upside on the headline figures and growth from its monthly active users and from its daily active users.
Intel Corp. (NASDAQ:INTC) Cowen maintained it as Market Perform and raised its target to 64 from 55. Wells Fargo maintained an Equal Weight rating and raised its target to 70 from 58. Loop Capital downgraded Intel to Sell from Hold with a 59 target price. Morgan Stanley reiterated its Overweight rating and raised its target price to 71 from 66.
Pacira BioSciences Inc. (NASDAQ:PCRX) was started as Buy at SunTrust Robinson Humphrey, and the 60 target price compared with a 44.09 close. The firm sees continued Exparel momentum driving the shares.
WPX Energy Inc. (NYSE:WPX) was reiterated as Overweight and the target price was raised to 18 from 17 at Wells Fargo.
Have a terrific week.
Latest posts by Paul Ebeling (see all)
- Wall Street’s Key Stock Analysts Research Report, All Buys - March 30, 2020
- Commentary: Paul Ebeling on Wall Street, World Vs Coronavirus - March 30, 2020
- Gold: Conditions Setting Up for the Price to 2X - March 30, 2020